Skip to main content

Immune Response BioPharma, Inc.

Home
Drug Discovery
Press Releases
Investor Relations
Royalties
Stock Information
Executive Team
Scientific Board
Clinical Trials
REMUNE Vaccine
REMUNE Rx Co-pay Card
REMUNEX Vaccine
RemuneVax Vaccine
NeuroVax Vaccine
NeurOral
RAVAX Vaccine
RAVAX II Vaccine
Zorcell Vaccine
DermaVax
Immunereszumab
Sepsicillin
Rare Diseases
Alliances
Vaccines Direct
Partnering
Bio Defense
Orchestra Therapeutics
Research Donations
About Us
Corporate Filings
Corporate ByLaws
Transfer Agent
Employment
Events
Webcast
Contact Us
Email Alerts
Member Login
Site Map

Immune Response BioPharma, Inc. TM  © 2010-2015

The Vaccine Development Company for the 21st Century & Beyond 

Home Page
undefinedundefined

Auto-Immune & Infectious Disease Drug Discovery & Research
Mission to Become the World Leader In Saving Lives & Vaccine Technology

Drug Discovery Pipeline
NeuroVax TM First in Class MS Vaccine FDA FastTrack
SPMS & Orphan Pediatric Designations   

REMUNE TM  First in Class Rescue HIV/AIDS Vaccine
 & FDA Orphan Pediatric Designation 

NeuroVax Granted FDA Pediatric Orphan Designation 
& FDA Fast Track Designation for SPMS

REMUNE Granted FDA Pediatric Orphan Designation 
 



Immune Response BioPharma, Inc. TM
 All Rights Reserved
                                                                           




  
Copyright © 2010-2015